Toxic effects of copper-based antineoplastic drugs (Casiopeinas) on mitochondrial functions.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical Pharmacology

• Publication date

  2003-06-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(03)00212-0PMID 12787878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Succinate dehydrogenase.

  2020cited by this paper
• Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice

  2004cited by this paper
• Mitochondria as a Pharmacological Target

  2002cited by this paper
• Modulation of a Plant Mitochondrial K+ATP Channel and Its Involvement in Cytochrome c Release

  2002cited by this paper
• Knigth's Move in the Periodic Table, From Copper to Platinum, Novel Antitumor Mixed Chelate Copper Compounds, Casiopeinas, Evaluated by an in Vitro Human and Murine Cancer Cell Line Panel

  2001cited by this paper
• Mitochondrial DNA in human malignancy.

  2001cited by this paper
• Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria.

  2001cited by this paper
• Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells.

  2000cited by this paper
• Modulation of 2-oxoglutarate dehydrogenase complex by inorganic phosphate, Mg(2+), and other effectors.

  2000cited by this paper
• Sulfite and membrane energization induce two different active states of the Paracoccus denitrificans F0F1-ATPase.

  2000cited by this paper
• Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells.

  2000cited by this paper
• Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin

  1999cited by this paper
• Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart.

  1999cited by this paper
• Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function.

  1998cited by this paper
• Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved?

  1998cited by this paper
• Fatty acid‐induced uncoupling of oxidative phosphorylation is partly due to opening of the mitochondrial permeability transition pore

  1998cited by this paper
• Mitochondrial control of apoptosis: the role of cytochrome c.

  1998cited by this paper
• Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis.

  1997cited by this paper
• Ternary copper complexes and manganese (III) tetrakis(4-benzoic acid) porphyrin catalyze peroxynitrite-dependent nitration of aromatics.

  1997cited by this paper
• Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain.

  1997cited by this paper
• Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application.

  1997cited by this paper
• MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.

  1996cited by this paper
• Cuprous ions activate glibenclamide-sensitive potassium channel in liver mitochondria.

  1996cited by this paper
• Modulation of 2-oxoglutarate dehydrogenase and oxidative phosphorylation by Ca2+ in pancreas and adrenal cortex mitochondria.

  1995cited by this paper
• Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells.

  1995cited by this paper
• Changes in the distribution of the control of the mitochondrial oxidative phosphorylation in regenerating rabbit liver.

  1994cited by this paper
• cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.

  1994cited by this paper
• Control of oxidative phosphorylation in AS-30D hepatoma mitochondria.

  1993cited by this paper
• Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.

  1992cited by this paper
• The interaction of platinum antitumour drugs with mouse liver mitochondria.

  1992cited by this paper
• Distribution of control of oxidative phosphorylation in mitochondria oxidizing NAD-linked substrates.

  1991cited by this paper
• Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells.

  1990cited by this paper
• Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules.

  1990cited by this paper
• A possible cellular mechanism of cisplatin-induced nephrotoxicity.

  1989cited by this paper
• Dependence of cardiac mitochondrial pyruvate dehydrogenase activity on intramitochondrial free Ca2+ concentration.

  1988cited by this paper
• Mitochondrial DNA damage by bleomycin.

  1987cited by this paper
• Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.

  1987cited by this paper
• Determination of the P/2e- stoichiometries at the individual coupling sites in mitochondrial oxidative phosphorylation. Evidence for maximum values of 1.0, 0.5, and 1.0 at sites 1, 2, and 3.

  1987cited by this paper
• Basis for the selective cytotoxicity of rhodamine 123.

  1987cited by this paper
• Mitochondrial alterations in cisplatin-induced acute renal failure.

  1986cited by this paper
• Regulation of oxidative phosphorylation in mitochondria by external free Ca2+ concentrations.

  1985cited by this paper
• Increased rhodamine 123 uptake by carcinoma cells.

  1985cited by this paper
• Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells.

  1985cited by this paper
• Correlation between response to cisplatinum‐combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck

  1984cited by this paper
• Uptake and metabolism of cisplatin by rat kidney.

  1984cited by this paper
• Minireview. The nephrotoxicity of cisplatin.

  1983cited by this paper
• The nephrotoxicity of cisplatin

  1983cited by this paper
• Cis-platinum in the treatment of testicular and other cancers.

  1982cited by this paper
• Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells.

  1982cited by this paper
• Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis.

  1982cited by this paper
• Acute and chronic cisplatin nephropathy in rats.

  1981cited by this paper
• Nephrotoxic acute renal failure due to common drugs.

  1981cited by this paper
• Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene.

  1980cited by this paper
• Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA

  1980cited by this paper
• Subcellular localization of cis-dichlorodiammineplatinum(II) in rat kidney and liver.

  1980cited by this paper
• Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys.

  1980cited by this paper
• Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations.

  1980cited by this paper
• Effects of chronic ethanol intoxication on oxidative phosphorylation in rat liver submitochondrial particles.

  1979cited by this paper
• Cis-diamminedichloroplatinum (II). A new anticancer drug.

  1977cited by this paper
• The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria.

  1974cited by this paper
• Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).

  1973cited by this paper
• Biochemistry of Mitochondria

  1966cited by this paper

• Synthesis, crystal structure elucidation, antimicrobial activity, DNA interaction and molecular docking studies of a copper(II) complex of 2,9-dimethyl-1,10-phenanthroline and phthalic acid

  2025cites this paper
• Doble synergetic anticancer activity through a combined chemo-photodynamic therapy and bioimaging of a novel Cas-ZnONPs all-in-one system.

  2024cites this paper
• D,L-Citrullinato-bipyridine Copper Complex: Experimental and Theoretical Characterization

  2023cites this paper
• Copper-instigated modulatory cell mortality mechanisms and progress in oncological treatment investigations

  2023cites this paper
• Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development

  2023cites this paper
• Modulators of mitochondrial ATP-sensitive potassium channel affect cytotoxicity of heavy metals: Action on isolated rat liver mitochondria and AS-30D ascites hepatoma cells.

  2023cites this paper
• Casiopeinas of Third Generations: Synthesis, Characterization, Cytotoxic Activity and Structure–Activity Relationships of Mixed Chelate Compounds with Bioactive Secondary Ligands

  2022cites this paper
• 5-Hydroxyisophthalic acid and neocuproine containing copper(II) complex as a promising cytotoxic agent: Structure elucidation, topology, Hirshfeld surface, DFT calculations, and molecular docking analysis

  2022cites this paper
• DNA, a target of mixed chelate copper(II) compounds (Casiopeinas®) studied by electrophoresis, UV-vis and circular dichroism techniques.

  2022cites this paper
• Antitumor activity via apoptotic cell death pathway of water soluble copper(II) complexes: effect of the diamino unit on selectivity against lung cancer NCI-H460 cell line

  2021cites this paper
• Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action

  2021cites this paper
• Spectroscopic and Small-angle X-ray scattering analysis of binding between Copper(II) -1-allylimidazole complex, a potential anti-tumor agent, and bovine serum albumin.

  2021cites this paper
• Anticancer Potency of Copper(I) Complexes Against a Range Cancer Cell Lines: A Review

  2021cites this paper
• Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes

  2020cites this paper
• Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells

  2020cites this paper
• Synthesis, structural characterization and antiproliferative activity on MCF-7 and A549 tumor cell lines of [Cu(N-N)(β3-aminoacidate)]NO3 complexes (Casiopeínas®)

  2020cites this paper
• Pharmacophoric sites of anticancer metal complexes located using quantum topological atomic descriptors

  2020cites this paper
• Theoretical determination of half-wave potentials for phenanthroline-, bipyridine-, acetylacetonate-, and glycinate-containing copper (II) complexes

  2020cites this paper
• Mitochondria-Targeting Anticancer Metal Complexes.

  2019cites this paper
• Effects of copper and temperature on heart mitochondrial hydrogen peroxide production.

  2019cites this paper
• Cu(ii) phenanthroline-phenazine complexes dysregulate mitochondrial function and stimulate apoptosis.

  2019cites this paper
• Casiopeina II-gly acts on lncRNA MALAT1 by miR-17-5p to inhibit FZD2 expression via the Wnt signaling pathway during the treatment of cervical carcinoma

  2019cites this paper
• Binucleating Hydrazonic Ligands and Their μ-Hydroxodicopper(II) Complexes as Promising Structural Motifs for Enhanced Antitumor Activity.

  2019cites this paper
• Structural Diversity, Electrochemical, and DNA-Binding Properties of Copper(II) Carboxylates

  2018cites this paper
• Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.

  2018cites this paper
• Ex Vivo Cardiotoxicity of Antineoplastic Casiopeinas Is Mediated through Energetic Dysfunction and Triggered Mitochondrial-Dependent Apoptosis

  2018cites this paper
• Investigating the hazards posed by pristine and modified copper nanomaterials using in vitro screens combined with in vivo models

  2018cites this paper
• Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells

  2018cites this paper
• Identification of Casiopeina II-gly secondary targets through a systems pharmacology approach

  2018cites this paper
• New copper(II) thiohydantoin complexes: Synthesis, characterization, and assessment of their interaction with bovine serum albumin and DNA.

  2017cites this paper
• Cytotoxic and genotoxic actions of Casiopeina III-Ea (Cas III-Ea) in somatic and germ cells of Drosophila melanogaster

  2017cites this paper
• Liver mitochondrial dysfunction and electron transport chain defect induced by high dietary copper in broilers

  2017cites this paper
• Novel copper(II) complexes with hydrazides and heterocyclic bases: Synthesis, structure and biological studies.

  2017cites this paper
• Hypoglycemia Enhances Epithelial‐Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids

  2017cites this paper
• Spectroscopic and Coordination Behavior of Ascorbic Acid Towards Copper (II) Ion

  2017cites this paper
• Synthesis, crystal and molecular structure of the copper(II) aminate complex with methionine

  2017cites this paper
• Genotoxic assessment of the copper chelated compounds Casiopeinas: Clues about their mechanisms of action.

  2017cites this paper
• A THERAPEUTIC JOURNEY OF MIXED LIGAND COMPLEXES CONTAINING 1,10- PHENANTHROLINE DERIVATIVES: A REVIEW Review Article

  2016cites this paper
• Structural Diversity, Electrochemical, and DNA-Binding Properties of Copper(II) Carboxylates

  2016cites this paper
• Copper(II) complexes with aromatic nitrogen-containing heterocycles as effective inhibitors of quorum sensing activity in Pseudomonas aeruginosa

  2016cites this paper
• Experimental and theoretical studies of copper complexes with isomeric dipeptides as novel candidates against breast cancer.

  2016cites this paper
• Synthesis, cytotoxic and antitubercular activities of copper(II) complexes with heterocyclic bases and 3-hydroxypicolinic acid

  2016cites this paper
• Pharmacological Activity of a Few Transition Metal Complexes: A Short Review

  2016cites this paper
• Effect of [Cu(4,7-dimethyl-1,10-phenanthroline)(acetylacetonato)]NO3, Casiopeína III-Ea, on the activity of cytochrome P450.

  2016cites this paper
• A THERAPEUTIC JOURNEY OF MIXED LIGAND COMPLEXES CONTAINING 1,10-PHENANTROLINE DERIVATIVES: A REVIEW

  2016cites this paper
• Transition-metal norharmane compounds as possible cytotoxic agents: New insights based on a coordination chemistry perspective.

  2016cites this paper
• Molecular Basis for Anticancer and Antiparasite Activities of Copper-Based Drugs

  2016cites this paper
• In vitro DNA damage by Casiopeina II-gly in human blood cells

  2016cites this paper
• Antineoplastic copper coordinated complexes (Casiopeinas) uncouple oxidative phosphorylation and induce mitochondrial permeability transition in cardiac mitochondria and cardiomyocytes

  2016cites this paper
• Mitochondrial free fatty acid β-oxidation supports oxidative phosphorylation and proliferation in cancer cells.

  2015cites this paper
• Warburg Effect or Reverse Warburg Effect? A Review of Cancer Metabolism

  2015cites this paper
• Doubly end-on azido bridged mixed-valence cobalt trinuclear complex: Spectral study, VTM, inhibitory effect and antimycobacterial activity on human carcinoma and tuberculosis cells.

  2015cites this paper
• Intercalation processes of copper complexes in DNA

  2015cites this paper
• Dual regulation of energy metabolism by p53 in human cervix and breast cancer cells.

  2015cites this paper
• A Ni(II) dinuclear complex bridged by end-on azide-N and phenolate-O atoms: spectral interpretation, magnetism and biological study

  2015cites this paper
• Coordination compounds in cancer: Past, present and perspectives

  2015cites this paper
• DNA-binding mode of antitumoral copper compounds (Casiopeinas®) and analysis of its biological meaning

  2015cites this paper
• Canonical and new generation anticancer drugs also target energy metabolism

  2014cites this paper
• Organo-Metallic Compounds: Novel Molecules in Cancer Therapy

  2014cites this paper
• Who controls the ATP supply in cancer cells? Biochemistry lessons to understand cancer energy metabolism.

  2014cites this paper
• The π-back-bonding modulation and its impact in the electronic properties of Cu(II) antineoplastic compounds: an experimental and theoretical study.

  2014cites this paper
• Pharmacokinetics and hematotoxicity of a novel copper‐based anticancer agent: Casiopeina III‐Ea, after a single intravenous dose in rats

  2014cites this paper
• Structural characterization of cobalt(II) complexes of an N,O donor Schiff base and their activity on carcinoma cells

  2014cites this paper
• Ultrastructure of metallopeptide-based soft spherical morphologies

  2014cites this paper
• The Effect of Iron and Copper as an Essential Nutrient on Mitochondrial Electron Transport System and Lipid Peroxidation in Trichoderma harzianum

  2013cites this paper
• Bax induces cytochrome c release by multiple mechanisms in mitochondria from MCF7 cells

  2013cites this paper
• Reactive oxygen species are generated by the respiratory complex II – evidence for lack of contribution of the reverse electron flow in complex I

  2013cites this paper
• Analysis of Apoptotic and Autophagic Pathways in Neuroblastoma by Treatment with Copper Compounds

  2013cites this paper
• Synthesis, Structural Characterization and Biological Activity of Cu(II) Compounds Incorporating Pyrazole‐derived Ligand: Effect on Cell Growth in Human Colorectal Carcinoma

  2012cites this paper
• New achievements on biological aspects of copper complexes Casiopeínas®: interaction with DNA and proteins and anti-Trypanosoma cruzi activity.

  2012cites this paper
• Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole.

  2012cites this paper
• Molecular recognition between DNA and a copper-based anticancer complex.

  2012cites this paper
• Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation

  2012cites this paper
• Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation

  2012cites this paper
• The metal-coordinated Casiopeína IIIEa induces the petite-like phenotype in Saccharomyces cerevisiae

  2011cites this paper
• Cytotoxic copper (II) mixed ligand complexes: crystal structure and DNA cleavage activity.

  2011cites this paper
• The importance of mitochondria in the tumourigenic phenotype: gliomas as the paradigm (review).

  2011cites this paper
• Copper and Its Complexes in Medicine: A Biochemical Approach

  2011influential citation
• Genotoxicity of the copper antineoplastic coordination complexes casiopeinas.

  2011cites this paper
• π-Stacking between Casiopeinas® and DNA bases.

  2011cites this paper
• Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells.

  2011cites this paper
• Copper compounds in cancer chemotherapy.

  2010cites this paper
• Casiopeína IIgly-induced oxidative stress and mitochondrial dysfunction in human lung cancer A549 and H157 cells.

  2010cites this paper
• Pharmacokinetics of Casiopeína IIgly in Beagle Dog: A Copper Based Compound with Antineoplastic Activity

  2010cites this paper
• Metabolic control analysis indicates a change of strategy in the treatment of cancer.

  2010cites this paper
• 2,2'-bipyridyl based copper complexes down regulate expression of pro-inflammatory cytokines and suppress MAPKs in mitogen induced Peripheral blood mononuclear cells.

  2010cites this paper
• Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger.

  2010cites this paper
• Targeting of cancer energy metabolism.

  2009cites this paper
• Copper compounds in anticancer strategies.

  2009cites this paper
• Antiproliferative activity and QSAR study of copper(II) mixed chelate [Cu(N-N)(acetylacetonato)]NO3 and [Cu(N-N)(glycinato)]NO3 complexes, (Casiopeínas).

  2009cites this paper
• Copper complexes as anticancer agents.

  2009cites this paper
• Interaction of Cu-dipeptide complexes with Calf Thymus DNA and antiproliferative activity of (Cu(ala-phe)) in osteosarcoma-derived cells

  2009cites this paper
• Cytotoxicity of copper(II) complexes of N-salicylidene-L-glutamate: modulation by ascorbic acid.

  2008cites this paper
• Energy metabolism transition in multi‐cellular human tumor spheroids

  2008influential citation
• Casiopeinas IIgly and IIIia Induce Apoptosis in Medulloblastoma Cells

  2008cites this paper
• Casiopeina III-ia induces apoptosis in HCT-15 cells in vitro through caspase-dependent mechanisms and has antitumor effect in vivo

  2008cites this paper
• Copper-adenine complex, a compound, with multi-biochemical targets and potential anti-cancer effect.

  2008cites this paper
• The effect of some 1-[4-(2-diethylaminoethoxy)phenylcarbonyl]-3,5-bis (benzylidene)-4-piperidone methiodides and related compounds on respiration and swelling of rat liver mitochondria.

  2008cites this paper
• New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.

  2008cites this paper
• Casiopeína IIgly induced cytotoxicity to HeLa cells depletes the levels of reduced glutathione and is prevented by dimethyl sulfoxide.

  2008cites this paper